Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study

No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabbous, Hany M., Abd-Elsalam, Sherief, El-Sayed, Manal H., Sherief, Ahmed F., Ebeid, Fatma F. S., El Ghafar, Mohamed Samir Abd, Soliman, Shaimaa, Elbahnasawy, Mohamed, Badawi, Rehab, Tageldin, Mohamed Awad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829645/
https://www.ncbi.nlm.nih.gov/pubmed/33492523
http://dx.doi.org/10.1007/s00705-021-04956-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829645/
https://www.ncbi.nlm.nih.gov/pubmed/33492523
http://dx.doi.org/10.1007/s00705-021-04956-9

Ejemplares similares